[New therapeutic options for smoking cessation. Nicotine polacrilex tablets for tobacco cessation].
Noé
Stefan
S
GlaxoSmithKline Consumer Healthcare GmbH & Co KG, Scientific Information, Bussmatten 1, 77815 Bühl.
D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010349:Patient Compliance; D011109:Polymethacrylic Acids / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D011145:Polyvinyls / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016540:Smoking Cessation / Q000379:methods*; D061485:Tobacco Use Cessation Devices
D000697:Central Nervous System Stimulants; D011109:Polymethacrylic Acids; D011145:Polyvinyls; D009538:Nicotine